🚨 Excited to join the #ESMO26 @OncoAlert PULSE Faculty for melanoma & early drug development! 💥 My 10 trials to watch (pic 👇🏼) INTerpath-001 || MOIO || DeLLphi-305 || HARMONi-GI1 || KRASCENDO-1 || CLARITY-Gastric 01 || HERIZON-GEA-01 || NATALEE || SAFFRON/SANOVO || KEYNOTE-B49 And yes, the melanoma trial is #1. Entirely objective ranking, of course 😉 Madrid has a PULSE (an @OncoAlert one 🖤) @myESMO @_SEOM @OncoReporte @GrupoMelanoma